ISL-1-positive MSCs (IsletOne)

N/A

Report date: 2023/01/12 15:31:29

Base Information

Drug NameISL-1-positive MSCs (IsletOne)
Drug Alias NameIO-1
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsHeart Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesIsletone
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIsletone
Active IndicationsN/A
Inactive IndicationsHeart Diseases

Other Information

ATC CodeN/A
Related LinksN/A